HALOZYME THERAPEUTICS, INC. ($HALO)
Filing Information
| Accession Number | 0001159036-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 6, 2026 |
| Document Date | Feb 3, 2026 |
| Document | View SEC Filing |
Transactions
13
Total Shares
150,000
Total Value
$5,060,503.25
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 3, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 728,719 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 3, 2026 | Sale | 2,551 | $74.88 | $191,016.33 | 726,168 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 3, 2026 | Sale | 9,659 | $75.94 | $733,543.10 | 716,509 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 3, 2026 | Sale | 7,790 | $76.73 | $597,757.86 | 708,719 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 4, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 728,719 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 4, 2026 | Sale | 9,900 | $76.94 | $761,666.40 | 718,819 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 4, 2026 | Sale | 10,100 | $77.54 | $783,154.00 | 708,719 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 5, 2026 | Exercise/Conversion | 10,000 | $12.07 | $120,700.00 | 718,719 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 5, 2026 | Sale | 5,376 | $78.38 | $421,365.50 | 713,343 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 5, 2026 | Sale | 4,624 | $78.94 | $365,000.06 | 708,719 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Feb 3, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 231,923 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Feb 4, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 211,923 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Feb 5, 2026 | Exercise/Conversion | 10,000 | $12.07 | $120,700.00 | 201,923 | Direct | โ | View Details |